BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 25994249)

  • 1. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
    EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrent ischemic stroke in patients with patent foramen ovale: The role of D-dimer.
    Park S; Kwon B; Oh JK; Song JK; Lee JS; Kwon SU
    J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107246. PubMed ID: 37536016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
    Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism.
    Ozdemir AO; Tamayo A; Munoz C; Dias B; Spence JD
    J Neurol Sci; 2008 Dec; 275(1-2):121-7. PubMed ID: 18822432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent foramen ovale and infarct volume in cryptogenic stroke.
    Jung JM; Lee JY; Kim HJ; Do Y; Kwon SU; Kim JS; Song JK; Kang DW
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1399-404. PubMed ID: 23747019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
    Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
    Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent foramen ovale and cryptogenic stroke.
    Nakanishi K; Yoshiyama M; Homma S
    Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R; Parreira L; Amador P; Silvestre I; Antunes C; Caria R
    J Echocardiogr; 2019 Mar; 17(1):44-51. PubMed ID: 30008156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
    Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP;
    Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Pelvic Vein Pathology in Patients with Cryptogenic Stroke and Patent Foramen Ovale Undergoing MRV Pelvis.
    Osgood M; Budman E; Carandang R; Goddeau RP; Henninger N
    Cerebrovasc Dis; 2015; 39(3-4):216-23. PubMed ID: 25791718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.